0000899243-20-008551.txt : 20200316 0000899243-20-008551.hdr.sgml : 20200316 20200316215040 ACCESSION NUMBER: 0000899243-20-008551 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200312 FILED AS OF DATE: 20200316 DATE AS OF CHANGE: 20200316 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Stueland Katherine CENTRAL INDEX KEY: 0001689575 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36847 FILM NUMBER: 20719150 MAIL ADDRESS: STREET 1: 458 BRANNAN STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94107 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Invitae Corp CENTRAL INDEX KEY: 0001501134 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 271701898 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1400 16TH STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94103 BUSINESS PHONE: (415) 374-7782 MAIL ADDRESS: STREET 1: 1400 16TH STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94103 FORMER COMPANY: FORMER CONFORMED NAME: InVitae Corp DATE OF NAME CHANGE: 20121105 FORMER COMPANY: FORMER CONFORMED NAME: Locus Development Inc DATE OF NAME CHANGE: 20100910 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-03-12 0 0001501134 Invitae Corp NVTA 0001689575 Stueland Katherine C/O INVITAE CORPORATION 1400 16TH STREET SAN FRANCISCO CA 94103 0 1 0 0 Chief Commercial Officer Common Stock 2020-03-12 4 A 0 91733 0.00 A 224786 D Common Stock 2020-03-13 4 S 0 935 11.5775 D 223851 D Common Stock 2020-03-13 4 S 0 65 12.60 D 223786 D Common Stock 2020-03-16 4 S 0 10684 11.79 D 213102 D Shares issued upon settlement of a restricted stock unit award that vests in three equal installments, with 1/3 of the remaining award vesting on each of March 12, 2021 and March 12, 2022, subject to continued service with the Issuer through the applicable vesting dates. These sales of common stock were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on August 22, 2019. Represents weighted average sale price. Actual sale prices ranged from $11.20 to $12.00. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated. Represents the sale of shares to cover tax withholding obligations associated with the vesting and settlement of restricted stock units. Represents a weighted average sale price. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold. Includes an aggregate of 172,173 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested. /s/ Katherine Stueland 2020-03-16